SEARCH

SEARCH BY CITATION

References

  • Adam BD, Maticka-Tyndale E & Cohen JJ (2003) Adherence practices among people living with HIV. AIDS Care 15, 263.
  • Amico KR, Harman JJ & Johnson BT (2006) Efficacy of antiretroviral therapy adherence interventions. A research synthesis of trials, 1996 to 2004. Journal of Acquired Immune Deficiency Syndromes, 41, 285297.
  • Bangsberg DR, Acosta EP, Gupta R et al. (2006) Adherence–resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS, 20, 223231.
  • Brown DM, Thorne JE, Foster GL et al. (2006) Factors affecting attrition in a longitudinal study of patients with AIDS. AIDS Care, 18, 821829.
  • Central Statistical Agency and ORC Macro (2006) Ethiopia Demographic and Health Survey 2005, Addis Ababa Ethiopia and Calverton, Maryland, USA.
  • Gordillo V, Del Amo J, Soreno V et al. (1999) Socio demographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 13, 17631769.
  • Herrera B, Gato A & Gaspar G. (1992) [Follow-up of the patient with HIV infection: a hospital task?] Atencion Primaria, 9, 251254.
  • Hogg RS, Heath K, Bangsberg D et al. (2002) Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS, 16, 10511058.
  • Kwong-Leung Yu J, Chih-Cheng SC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bulletin of the World Health Organization, 85, 550554.
  • Malcolm SE, Ng JJ, Rosen RK & Stone VE (2003) An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care 15, 251.
  • Malta M, Petersen ML, Clair S, Freitas F & Bastos FI (2005) Adherence to antiretroviral therapy: a qualitative study with physicians from Rio de Janeiro, Brazil. Cad. Saude Publica, 21, 14241432.
  • Mengesha A. et al. , (2005). Assessment of Adherence to Antiretroviral Therapy Among HIV-Infected Persons in the Ministry of National Defense Force Hospitals, Addis Ababa and Debreziet. MPH thesis, Addis Ababa University.
  • Ministry of Health (2005) Guideline for Implementation of Antiretroviral Therapy in Ethiopia, Addis Ababa Ethiopia, Federal HIV/AIDS Prevention and Control Office, Federal Ministry of Health.
  • Ministry of Health. (2006). AIDS in Ethiopia, 6th Edition, Disease Prevention and Control Department, Ministry of Health, Addis Ababa.
  • Palella FJ, Delaney K, Moorman A et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853860.
  • Panos Global AIDS Program, (2006) Antiretroviral Drugs for all? Obstacles to Access to HIV/AIDS: Treatment Lessons From Ethiopia, Haiti, India, Nepal and Zambia. Available at http://www.etharc.org/arvinfo/arvsforall.pdf. Panos Global AIDS Programme, Lusaka.
  • Papasavvas E, Ortiz GM, Gross R et al. (2000) Enhancement of human immunodeficiency virus type-1 specific CD4 and CD8 T cells responses in chronically infected persons after temporary treatment interruption. Journal of Infectious Diseases, 182, 766775.
  • Quava-Jones A & Barthlomew C. (2004) Challenges faced with adherence and defaulters at and HIV treatment clinic, Port of Spain, Trinidad. International Conference on AIDS. 15, 1116 abstract no. WePeB5805.
  • Spire B, Duran S, Souville M, Leport C, Raffi F & Moattia J-P (2002) Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Social Science & Medicine 54, 14811496.
  • Steele RG, Anderson B, Rindel B et al. (2001) Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care, 13, 617629.